Introduction: The ability to reproducibly identify clinically equivalent patient populations is critical to the vision of learning health care systems that implement and evaluate evidence-based treatments. The use of common or semantically equivalent phenotype definitions across research and health care use cases will support this aim. Currently, there is no single consolidated repository for computable phenotype definitions, making it difficult to find all definitions that already exist, and also hindering the sharing of definitions between user groups.
Introduction
Computable phenotypes, or electronic health record (EHR)-based condition definitions, enable the identification of cohorts of patients with certain diseases or clinical profiles for disease management registries, quality improvement programs, evaluation studies, and interventional research. Regardless of the application, cohort identification requires queries of clinical data stores that are both valid and reproducible. Currently, there is no single consolidated repository for computable phenotypes, making it difficult to find all definitions that already exist, and also hindering the sharing of definitions between user groups. Health services researchers and quality assessment groups-i.e., the National Quality Forum (NQF), National Committee for Quality Assurance (NCQA), the Centers for Medicare & Medicaid Services (CMS), and the Agency for Healthcare Research and Quality (AHRQ)-provide computable phenotypes on a number of websites. [1] [2] [3] [4] [5] In addition, researchers and registry developers create definitions utilizing different design and evaluation methods. Because the definitional logic is often underspecified or unreported in scientific journals, it is not clear if the findings reported in published research or quality improvement are comparable or relevant to clinical populations, hindering the application of evidence-based medical and nursing care.
We believe that a minimal set of well-constructed and explicit EHR-based phenotype definitions will create efficiencies for health care organizations that must increasingly support growing numbers of data requests related to comparative effectiveness research (CER), quality improvement, and chronic disease management. We further believe that such a set will facilitate synergies between research and care delivery, enabling "learning health care" practices 6 and subsequently improving patient outcomes. A large-scale and multipurpose approach to sharing phenotype definitions will support the reuse of well-constructed and validated computable phenotypes, and will subsequently reduce the variation in definitions across conditions. Drawing from our experience from an academic medical center supporting a number of multisite research projects, we articulate a framework that will support the sharing of phenotype definitions across research and health care use cases, and highlight gaps or areas that need attention and collaborative solutions.
Background and Context
A "computable phenotype" is a definition of a condition, disease, or characteristic or clinical event that is based solely on data that can be processed by a computer. 7 Computable phenotype definitions provide the specifications to identify populations of patients with conditions of interest, and can be combined with other criteria, such as age or other demographic information, to develop cohort populations for a variety of purposes.
Quality monitoring organizations (such as NQF, NCQA, and AHRQ) create computable phenotype definitions for the development and monitoring of health care quality measures. A number of research networks have developed phenotype definitions to enable the use of EHR data for observational research (including comparative effectiveness studies) and interventional trials. [8] [9] [10] [11] Various multisite studies 12, 13 use these definitions to develop registries for drug safety surveillance 14 or chronic disease management. 15 There are numerous and distinct use cases for computable phenotypes for health care delivery (e.g., personalized medicine, guidelinebased care, chronic disease management, and quality measurement) and biomedical research (genomic, observational, CER, health services research, and interventional trials.) Each use case represents different scientific disciplines whose phenotype development efforts have heretofore 16 The consequent likelihood that research, patient care, and quality measurement communities are using different phenotype definitions for the same condition is more concerning. The COPD Outcomes-based Network for Clinical Effectiveness & Research Translation (CONCERT) assessed 980 patients sampled from various EHR systems using a clinical phenotype definition for chronic obstructive pulmonary disease (COPD), and found that just over half of those met the criteria for the well-accepted research definition for the condition. 13 Further, they found that the patient populations retrieved by the clinical and research definitions for COPD had significantly different comorbidities and risk factors. 13 This implies that disease management registries and quality improvement programs might be identifying populations that are different from those used in the development of the evidence upon which those supporting treatment strategies and interventions are based.
The "research informs practice informs research" cycle that is the essence of learning health care systems entails that the clinical features used to define research and patient populations be well understood and comparable. Hence semantically equivalent phenotype definitions must be used to identify clinically equivalent populations. We believe that creating a centralized collection of explicitly defined computable phenotypes, with an accompanying knowledge base of development and validation documentation, is the first step toward consolidating effort and harmonizing definitions. Information, resources, and tools that facilitate the reuse of existing phenotypes will reduce the variation in phenotype definitions across all use cases, facilitate conversations between health care and research communities about how to compare definitions for different use cases, and ultimately lead to harmonization of definitions that will simplify and support the identification of clinically equivalent populations for research and health care purposes.
Framework Components
The reuse of phenotype definitions can be facilitated by their explicit representation and tools to support their evaluation and implementation in new applications. We propose that the deliberate and informed reuse of existing definitions will require four components: (1) searchable libraries of explicitly defined phenotype definitions; (2) supporting knowledge bases with information and methods; (3) tools to identify, evaluate, and implement existing phenotype definitions; and (4) motivated users and stakeholders to use them (Fig 1) . Mo and colleagues call for a formal computable representation of phenotype definitions that will enable scalability of the definitions by allowing them to be applied to different data systems. 17 Their desiderata includes the following: human-readable and computable forms, structured rules, formalisms for temporal relations, representations for text searching and natural language processing, and interfaces for external software algorithms. They endorse the use of standardized terminologies, ontologies, and also the reuse of value sets.
Additional information can be included in the library or underlying knowledge base to support users' semantic understanding of the phenotype definition, and to enable selection of the appropriate definition to identify patient cohorts with the intended clinical features. Therefore, the definitions in a phenotype library should include metadata or supporting information about a definition, its intended use, the clinical rationale or research justification for the definition, and data about clinical and scientific validation in various health care settings. As an example, actual blood pressure measurements, even when they are available for long periods, did not contribute significantly to predictive models for hypertension control. 18 Without clear supporting documentation, clinical subject matter experts may reject, as lacking face validity, well-validated phenotype definitions that do not match their expectations or intuition. Clinical practice and disease definitions change over time. Therefore, phenotype definitions in a phenotype library should reference the underlying clinical definitions or guidelines upon which they are based, in order to better identify legacy definitions that are out of date. In addition, phenotype definitions should conform to existing required and emerging terminologies and standards-e.g., SNOMED CT, LOINC, RxNorm, LOINC, NDF-RT-for representing clinical data, as endorsed by the Office of the National Coordinator. 19 Adherence to standards allows for a modular design that reduces development and implementation costs, particularly at scale where multiple use cases for that standard may exist concurrently.
Because phenotype definitions might perform differently when implemented in different patient populations and EHR systems, information about the performance of phenotypes in specific organizations should be collected from implementers and shared with future users. Implementation information is necessary to understand how standard definitions perform across diverse populations, heterogeneous organizations and EHRs systems. Specifically, information about the underlying population and quality (i.e., completeness, accuracy, consistency) of data that were used to validate the definitions have important implications for interpreting the validation results. For example, if a test population had 50 percent missing data in one of the defining variables for the phenotype, the provision of this information provides important contextual information about the definition's performance. Similarly, the testing of phenotype definitions in populations with high versus low prevalence of disease will yield different results. Recommendations for data quality assessment reporting in pragmatic trials 20 and observational research 21, 22 can provide insight into which data quality dimensions (e.g., completeness, accuracy) might be most useful to evaluate the phenotype definition.
To maximize the socialization and collaboration around shared phenotypes, the ideal phenotype library should support communication between phenotype developers and implementers. The Centers for Medicare & Medicaid Services (CMS) employs a standardized approach for enabling users to post questions and share comments, and for maintaining quality measure definitions across multiple programs. 23 Such a framework could be adapted for use with computable phenotype libraries. During early development, draft phenotype specifications could be posted in a library for public review to evaluate feasibility and refine use cases. During the validation phase, the testing methodology could be opened to public comment. Once validated, the library could facilitate communications of best practices and feedback. This would allow implementers to share information about their experiences implementing phenotype definitions in their local systems, and allow others to ask questions to inform the many practical decisions that are made when implementing abstract logic in local data systems. A collaborative or interactive component would also allow users to relate their experience implementing definitions in different vendor systems and in different patient populations. Over time, the library could collect data on usage and impact, and aggregate published literature based on each phenotype. A record of projects that have used or endorsed different phenotype definitions can enhance understanding of phenotype intent and performance, and can assist potential implementers in the selection of appropriate phenotypes. 
Tools
Formal representations of computable phenotypes, mappings to reference coding systems and (common) information models, and executable code can support the implementation of definitions in different populations. Mo's desiderata highlights recommendations for clinical data representation to support phenotyping. 17 This specifically calls for the structure of clinical data into queryable forms and the use of a common data model to support customization for the variability and availability of EHR data among sites. Since there currently are a number of (different) common data models used in research networks, [28] [29] [30] there is a need for tools and platforms to implement a given phenotype definition in different contexts. Knowledge, authoring tools, and vocabulary mapping tools to support these activities can also be centrally available through a shared knowledge base 31 or links to a code sharing base like GitHub. Similarly, the implementation of these definitions require terminology mappings (e.g., from drug class names in NDF-RT and medication sets from RxNorm to product codes in (NDC). 32 Terminology integration resources, such as RxNorm, the Unified Medical Language System (UMLS) and UMLS Terminology Services (UTS) tools, can benefit Note: *This represents a gap where tooling is needed. We are not aware of existing tools that support this function.
phenotype use cases in many networks. To be more broadly used, these tools should be centrally available with supporting instructions for people from many different domains and levels of technical expertise.
Specifically, tools are needed for the following uses: (1) searching for phenotype definitions that are endorsed or mandated; (2) browsing existing phenotypes to find ones that are potentially relevant that can be reused; (3) the display of relevant information to help potential implementers understand existing definitions and their strengths and limitations for particular uses; (4) the implementation of those definitions in local EHR systems with, e.g., executable code tailored to common data models, or mappings between coding systems; (5) 
Motivated Users and Stakeholders
The sharing of definitions and experience will require deliberate action on the part of potential phenotype developers and implementers, and useful and intuitive tools can support this behavior. Aligning existing computable phenotypes with users' needs will likely positively influence their uptake, as will engaging all stakeholders in the design and development of phenotype resources and tools described in this framework. Additionally, a number of approaches can be used to motivate individuals to search for existing definitions and to share the outcomes of computable phenotype implementations. Possible approaches include creating incentives, increasing perceived benefit, establishing new social norms, or regulating with policies or regulations.
Perceived Benefits and Value
Collaboration is fostered when the collaborators expect or perceive a beneficial outcome. The more beneficial or significant the outcome, the higher the participation and commitment level among collaborators will be. Wilcox et al. assert that the costs for sustaining research infrastructure can be covered if value can be created. 35 Thus, clear demonstrations of reduced workload, reduced costs, or faster development resulting from the reuse of phenotype definitions might motivate potential users. Incentives Tangible incentives can be created through policy or legislation. Examples include quality reporting incentives (e.g., the CMS Physician Quality Reporting System and the financial rewards of the Meaningful Use program), and punitive consequences for noncompliance with Food and Drug Administration (FDA) reporting specifications. Although these types of incentives might be effective, they are timeconsuming and expensive to achieve. Alternative incentives might derive from some sort of peer pressure from the scientific community to report phenotype definitions as part of the research protocol or study results reporting in publications, or rewards for such behavior from research sponsors or in academic promotion rubrics.
Shared Values and Principles
A set of agreed upon assumptions and principles for research networks, sponsors, and health care regulators to adopt is the first step in addressing the complex challenges to reusing phenotype definitions. These should include a stated commitment to reproducible science and the standardized reporting of phenotype definitions, use case, and validation results. Additional principles could include an expectation that users of computable phenotypes will search for and consider existing definitions before creating their own. For conditions where a phenotype definition already exists, researchers should carefully consider whether the benefit of developing new definitions tailored to their specific use cases outweighs the Scenario 1.
An intervention specialist working for the Southeastern Diabetes Initiative (SEDI) wants to identify patients with type 2 diabetes across a number of health care providers in order to develop treatment programs and community interventions that will improve diabetes care. The specialist needs operational definitions for type 2 diabetes, as well as a number of associated conditions such as hypertension and chronic kidney disease. She goes to a central phenotype library and finds definitions for each condition that are appropriate for broad population screening and that can be implemented in all the SEDI sites, including one with no capacity for accessing clinical notes. She shares a link for each selected phenotype definition, plus implementation guidance and appropriate code, with the data specialists at each SEDI site. Each site implements the definition and reports their results to the phenotype library. One SEDI site had problems with the code and reported this experience as well. The original developer of the phenotype contacted the SEDI site with a suggestion. This suggestion was helpful and was therefore added to the knowledge base for other SEDI sites to access and review. Later, the study was published in a journal and referenced the link to the computable phenotype logic and supporting implementation tools. Using these definitions and tools, a new group of researchers replicated the intervention in an urban population on the West Coast and published their findings.
This scenario was enabled by the following:
1. Searchable libraries of explicitly defined phenotype definitions; 2. Supporting knowledge bases with information and methods; 3. Supporting tools; and 4. Users and stakeholders motivated to consider reusing existing definitions; benefits from reuse and shared phenotype definitions were realized by the users.
Scenario 2.
A clinician reviews the literature and finds a study of a new medical intervention for uncontrolled hypertension. She wants to implement it on a similar population in her clinic. The published article includes a narrative discussion of the inclusion and exclusion criteria (e.g., includes diagnosis of hypertension and excludes chronic kidney disease) with hyperlinks to a public phenotype library that hosts the computable phenotype specifications for the intervention population. The clinician points her data analyst to the phenotype specifications and requests a data warehouse query to estimate the number of patients that might be eligible for the planned intervention. After obtaining the required institutional approvals, she implements the intervention and conducts a formal quality improvement study. She publishes that study and references a public link to the phenotype library and knowledge base for the specific computable phenotype-definition logic and supporting implementation tools. Future implementers access the library for implementation details, rather than contacting this clinical investigator, allowing her more time to research and plan new chronic disease management interventions.
1. 
Vision of Shared Phenotype Definitions
The need for a shared or common vision has been identified as important success factors in collaborative projects. We provide a vision in the form of two scenarios that might motivate pannetwork or cross-use case sharing of phenotype definitions (Box 1).
Communication, Marketing, and Engagement
Communication and marketing of a set of principles and vision might enhance the engagement, participation, and support of stakeholders from multiple organizations and domains. Communication campaigns that inform potential users about the availability of existing computable phenotypes and increase their perception that reusing existing definitions will save them work, or produce a better definition (that has been previously tested) than they can do alone. Professional societies and medical advocacy groups may choose to endorse and curate authoritative phenotypes as a complement to guideline development activities. Further, models of sharing behavior could be manufactured and made visible, such as online exchanges between investigators that describe challenges or observations in implementing particular definitions in certain settings. 36 illustrates a gap in learning health sciences that should be addressed. 37 The learning health care paradigm will demand continuous development and refinement of new phenotypes to identify conditions of interest and to reflect changes in health care practice and EHR systems. Clinicians, health care administrators, investigators, and patients benefit from the use of explicitly defined and validated definitions for sampling, potential research participant identification, and broader analyses using data from EHRs. Collaboration around the development of computable phenotypes for emerging diseases, especially where consensus in professional societies is slow to emerge (e.g., the early years of HIV/ AIDS) or varies over time, e.g., the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)'s new classification of the autism spectrum-which is not concordant with prior definitions, might expedite their investigation and build consensus in professional society guidelines in a rapid learning environment. Similarly, standardized processes to update and periodically revalidate definitions-as knowledge of disease increases, and as coded terminologies, EHRs and patterns of health care delivery mature-will be required.
Protection from Risks
The creation of a culture for sharing, reusing, and harmonizing phenotype definitions will require changes in thinking and behavior that can be enhanced by the following call to action for researchers and clinicians: (1) champion cultural changes and resource allocations that will enable the reuse of computable phenotype definitions where appropriate; (2) survey the landscape for existing and previously validated definitions that will meet the particular need before creating a new definition, and (3) provide phenotype definition logic and implementation performance or validation results, so that others can benefit from this knowledge.
The vision of shared phenotype definitions between research and health care activities will ultimately require governance structures to control curation of phenotype knowledge, raising a number of questions that will need to be addressed: Who should be the guardians of such knowledge-a centrally controlled federal agency or commercial entity, or both? What are the types of criteria that would be used to 1 
Conclusions and Call to Action
The implementation of learning health care systems is gaining momentum, and the ability to reproducibly identify clinically equivalent patient populations is critical to implementing and evaluating evidencebased treatments in health care systems. The use of common or semantically equivalent phenotype definitions across research and health care use cases can support this aim. A national infrastructure for reusing phenotype definitions and sharing experience across health care delivery and clinical research applications will reduce duplicate efforts and increase efficiencies. Both research and provider communities need access to a collection of existing definitions, information to evaluate their appropriateness for particular applications, a knowledge base of implementation guidance, supporting tools that are user-friendly and intuitive, and a willingness to use them. We encourage prospective researchers and health administrators to reuse existing EHR-based condition definitions where appropriate and to share their results with others to support a national culture of learning health care. A number of federally funded resources support these activities, and research sponsors should encourage their use.
